Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments. Ferraiuolo RM, Fifield BA, Hamm C, Porter LA, et al. Breast Cancer Res Treat 2022 Aug 27. pii: 10.1007/s10549-022-06715.

Read + Share

Amedeo Smart

Independent Medical Education

Ferraiuolo RM, Fifield BA, Hamm C, Porter LA, et al. Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments. Breast Cancer Res Treat 2022 Aug 27. pii: 10.1007/s10549-022-06715.
PMID: 36029387